Form 13-F position report

* MYRIAD GENETICS INC

Reported by Balyasny Asset Management LLC

Company profile Manager portfolio Source filing
MYGN CUSIP 62855J104 Manager CIK 0001218710
Latest reported change

Reported 1,446,745 shares, down 142,232 (9.0%) from the prior quarter.

Reported value -9.1%; share count -9.0% vs. the prior quarter.

Reduced
% of reported 13F value 0.07% This manager · Q2 2023
Shares 1,446,745 Quarter-end amount reported
Reported value $33,535,549 Fair value at quarter end
Consecutive quarters held 13 Through Q2 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Manager history

Quarterly position history

How this manager's reported quarter-end position changed over time.

17 quarters
Quarter Activity Shares Change % of reported 13F Reported value Filed
Q2 2026 New 36,860 +36,860 (0.0%) < 0.01% $210,471 2026-08-14
Q1 2026 Reduced 0 -16,155 (-100.0%) 0 $0 2026-05-15
Q4 2025 Reduced 16,155 -128,790 (-88.9%) < 0.01% $99,353 2026-02-17
Q3 2025 New 144,945 +144,945 (0.0%) < 0.01% $1,047,952 2025-11-14
Q2 2025 Reduced 0 -862,787 (-100.0%) 0 $0 2025-08-14
Q1 2025 Added 862,787 +779,405 (934.7%) 0.01% $7,652,921 2025-05-15
Q4 2024 New 83,382 +83,382 (0.0%) < 0.01% $1,143,167 2025-02-14
Q4 2023 Reduced 0 -290,808 (-100.0%) 0 $0 2024-02-14
Q3 2023 Reduced 290,808 -1,155,937 (-79.9%) < 0.01% $4,664,560 2023-11-14
Q2 2023 Reduced 1,446,745 -142,232 (-9.0%) 0.07% $33,535,549 2023-08-14
Q1 2023 New 1,588,977 +1,588,977 (0.0%) 0.09% $36,911,936 2023-05-15
Q4 2022 Reduced 0 -26,245 (-100.0%) 0 $0 2023-02-14
Q3 2022 Reduced 26,245 -8,755 (-25.0%) < 0.01% $501,000 2022-11-15
Q2 2022 Reduced 35,000 -286,067 (-89.1%) < 0.01% $636,000 2022-08-15
Q1 2022 New 321,067 +321,067 (0.0%) 0.03% $8,091,000 2022-05-16
Q4 2021 Reduced 0 -221,193 (-100.0%) 0 $0 2022-02-14
Q3 2021 New 221,193 +221,193 (0.0%) 0.03% $7,142,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history
Institutional context

Who else reported the position

211 managers reported * MYRIAD GENETICS INC for Q2 2023.

Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 14,104,604 -23,104 < 0.01% $326,944,722 41 qtrs
VANGUARD GROUP INC Reduced 9,152,347 -146,067 < 0.01% $212,151,404 41 qtrs
Camber Capital Management LP Reduced 6,635,000 -365,000 5.01% $153,799,000 16 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 5,744,834 -986,005 0.03% $133,165,252 10 qtrs
STATE STREET CORPORATION Added 4,722,988 +120,069 < 0.01% $109,478,862 41 qtrs
GLENVIEW CAPITAL MANAGEMENT LLC Reduced 3,744,888 -450,224 1.96% $86,806,504 16 qtrs
EARNEST PARTNERS LLC Added 3,253,778 +192,940 0.42% $75,422,574 16 qtrs
Bank of America Corporation Reduced 2,970,821 -462,148 < 0.01% $68,863,631 41 qtrs
DIMENSIONAL FUND ADVISORS LP Reduced 2,673,471 -50,925 0.02% $61,970,696 41 qtrs
Artisan Partners Limited Partnership Added 2,538,065 +331,207 0.09% $58,832,347 9 qtrs
A free account expands this comparison to 25 managers. Create free account
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2023
Filed
August 14, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
1,444,532
Shared
2,213
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.